UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10176
ProShares UltraShort Health Care
RXD
$3.01M
| $17 | ﹤0.01% |
1
-1
| -50% | -$20 |
2023 Q3
11 quarters
|
|
10177
Tradr 2X Long SMR Daily ETF
SMU
$65.7M
| $17 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
10178
CalciMedica
CALC
$9.6M
| $16 | ﹤0.01% |
3
| – | – |
2023 Q2
12 quarters
|
|
10179
PSQ Holdings Warrants
PSQH.WS
$859K
| $16 | ﹤0.01% |
394
-1,601
| -80% | -$96 |
2026 Q1
1 quarter
|
|
10180
ProShares Short Real Estate
REK
$11.6M
| $16 | ﹤0.01% |
1
| – | – |
2022 Q3
15 quarters
|
|
10181
Yoshitsu Co
TKLF
$7.76M
| $16 | ﹤0.01% |
8
-58
| -88% | -$123 |
2025 Q4
2 quarters
|
|
10182
Avalon Holdings
AWX
$9.9M
| $15 | ﹤0.01% |
6
-133
| -96% | -$336 |
2026 Q1
1 quarter
|
|
10183
DELISTED
Evolv Technologies Warrant
EVLVW
| $15 | ﹤0.01% |
+2,470
| New | +$226 |
2026 Q2
0 quarters
|
|
10184
BondBloxx High Yield Income ETF
HYSA
$111M
| $15 | ﹤0.01% |
+1
| New | +$15 |
2026 Q2
0 quarters
|
|
10185
DELISTED
Nutriband Inc Warrant
NTRBW
| $15 | ﹤0.01% |
15
| – | – |
2024 Q1
9 quarters
|
|
10186
ETRACS Monthly Pay 2x Leveraged Preferred Stock ETN
PFFL
$6.31M
| $15 | ﹤0.01% |
2
-65
| -97% | -$516 |
2023 Q3
11 quarters
|
|
10187
ProShares UltraPro Short MidCap400
SMDD
$2.11M
| $15 | ﹤0.01% |
2
| – | – |
2023 Q4
10 quarters
|
|
10188
Tradr 2X Long QBTS Daily ETF
QBTX
$97.1M
| – | – |
0
| – | – |
2026 Q2
0 quarters
|
|
10189
Canary Marinade Solana ETF Shares of Beneficial Interest
SOLC
$1.9M
| $15 | ﹤0.01% |
+1
| New | +$16 |
2026 Q2
0 quarters
|
|
10190
SeaStar Medical Holding Corp Warrant
ICUCW
$178K
| $14 | ﹤0.01% |
801
+84
| +12% | +$2 |
2026 Q1
1 quarter
|
|
10191
Erayak Power Solution Group
RAYA
$1.12M
| $14 | ﹤0.01% |
5
-223
| -98% | -$848 |
2025 Q4
2 quarters
|
|
10192
AdvisorShares Pure Cannabis ETF
YOLO
$33.1M
| $14 | ﹤0.01% |
5
-146
| -97% | -$432 |
2023 Q4
10 quarters
|
|
10193
Direxion Daily Energy Bear 2X ETF
ERY
$53.7M
| $13 | ﹤0.01% |
+1
| New | +$12 |
2026 Q2
0 quarters
|
|
10194
DELISTED
Valens Semiconductor Ltd Warrants
VLN.WS
| $13 | ﹤0.01% |
+478
| New | +$16 |
2026 Q2
0 quarters
|
|
10195
Virax Biolabs
VRAX
$1.48M
| $12 | ﹤0.01% |
+4
| New | +$17 |
2026 Q2
0 quarters
|
|
10196
Drugs Made In America Acquisition Corp Rights
DMAAR
| $12 | ﹤0.01% |
+108
| New | +$11 |
2026 Q2
0 quarters
|
|
10197
Black Hawk Acquisition Corp Units
BKHAU
$41.9M
| $12 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
10198
Willow Lane Acquisition Corp II Warrants
WLIIW
| $12 | ﹤0.01% |
+13
| New | +$10 |
2026 Q2
0 quarters
|
|
10199
MAX Airlines -3x Inverse Leveraged ETN
JETD
$642K
| $11 | ﹤0.01% |
5
| – | – |
2024 Q4
6 quarters
|
|
10200
enVVeno Medical
NVNO
$4.77M
| $11 | ﹤0.01% |
1
-242
| -100% | -$2.61K |
2023 Q4
10 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.